Testing effectiveness (Phase 2)Study completedNCT01656031
What this trial is testing
A Phase II Open-Label Study of High-Dose Cytarabine and Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Refractory or Relapsed Acute Lymphoblastic Leukemia
Who this might be right for
Leukemia
Wake Forest University Health Sciences 39